期刊文献+

VEGF、LN—R在卵巢癌中的表达及临床意义

Expression of VEGF and LN-R in Ovarian Cancer and Its Clinical Significance
下载PDF
导出
摘要 [目的]探讨血管内皮生长因子(VEGF)和层粘连蛋白受体(LN-R)在卵巢癌发生、发展中的作用和临床意义.[方法]用免疫组织化学SP法检测42例卵巢癌中VEGF和LN-R的表达,分析其表达与病理类型、组织学分级、FIGO分期有无转移的关系.[结果]①VEGF在卵巢癌中高水平表达78.6%(33/42); LN-R在卵巢癌中高水平表达83.3%(35/42).②卵巢癌临床分期越晚、组织学分化越差,伴有淋巴结或大网膜转移的卵巢癌中VEGF和LN-R的阳性表达率越高(P〈0.05).③VEGF阳性表达与LN-R阳性表达表现出相关性(P〈0.05).[结论]VEGF和LN-R在卵巢癌的发生和发展中呈协同一致的作用, VEGF和LN-R的阳性表达率与临床分期及组织学分级和有无转移有关,与病理类型无关,这为卵巢癌的诊断和治疗提供了依据. [Objective] To explore the role 'and clinical significance of vascular endothelial growth factor (VEGF) and laminin receptor(LN-R) in the occurrence and development of ovarian cancer. [Methods]The expression of VEGF and LN-R in 42 cases with ovarian cancer was detected by using immunohistochemical SP method. The relationship between the expression of VEGF or LN-R and histological type, histological grade, FIGO stage and metastasis was analyzed. [Results]The expression of VEGF and LN-R was high in ovarian cancer. The later the clinical stage of ovarian cancer, the worse the histological differentiation, and the higher the positive expression of VEGF and LN-R in ovarian cancer with lymph node and omentum majus metastasis ( P 〈0.05). The positive expression of VEGF was related with the positive expression of LN-R( P 〈0.05). [Conclusion]VEGF and LN R have the synergetic effect in the occurrence and development of ovarian cancer. The positive expression rate of VEGF and LN-R is related with the clinical stage, histological grading and metastasis, which provides a basis for the diagnosis and treatment of ovarian cancer.
出处 《医学临床研究》 CAS 2010年第5期854-856,共3页 Journal of Clinical Research
关键词 卵巢肿瘤/病理学 内皮生长因子/生物合成 受体 层粘连蛋白/生物合成 ovarian neoplasms/PA endothelial growth factors/BI receptors,lamir/in/BI
  • 相关文献

参考文献9

  • 1Davidson B,Risberg B,Bemer A,et al.The biological differences between ovarian serous carcinoma and diffuse peritoneal malignan mesothelioma[J].Semin Diagn Pathol,2006,23(1):35-43.
  • 2Lee J K,Hong Y J,Han C J,et al.Clinical usefulness of serum and plasma vascular endothelial growth factor in cancer patients:W hich is the optimal specimen[J] ?Int J Oncol,2000,17(1):149.
  • 3李恩孝,吴胤瑛,施璠.靶向VEGF治疗恶性肿瘤的研究进展[J].现代肿瘤医学,2006,14(3):370-372. 被引量:6
  • 4邢爽,刘耀文,罗庆良.血管内皮生长因子靶向治疗抗肿瘤作用机制[J].国际药学研究杂志,2008,35(6):454-457. 被引量:1
  • 5Colognato H,Yureheneo PD.Form and function:the laminina family of heterotrimers[J].Dev Dyn,2000,218(2):213-234.
  • 6龙娟,陈刚,吴明富,卢运萍,李静,王世宣,周剑峰,马丁.层粘连蛋白及其受体在卵巢癌组织中的表达及其临床意义[J].中华妇产科杂志,2003,38(12):763-764. 被引量:9
  • 7Givant-Horwitz V,Davidson B,et al.Expression of the 67 kDa Laminin receptor and the alpha integrin subunit in serous ovarian carcrinoma[J].Clin ExP Metastasis,2003,20(7):599-560.
  • 8Huang SH,Jong A.Evolving role of laminin receptors in microbial pathogenesis and therapeutics of CNS infection[J].Future Microbiol,2009,4(8):959-962.
  • 9Fatehullah A,Doherty C Pivato G,Allen G,et al.Interactions of the 67 kDa laminin receptor and its precursor with laminin[J].Biosci Rep,2009,30(2):73-79.

二级参考文献8

共引文献13

相关作者

内容加载中请稍等...

相关机构

内容加载中请稍等...

相关主题

内容加载中请稍等...

浏览历史

内容加载中请稍等...
;
使用帮助 返回顶部